Question
Asked 8 October 2016

How can we purchase psilocybin for human pilot study?

Hi, our research team wants to do a pilot-study on psilocybin. Does anyone have any idea on how we can buy this substance? Can anyone help us on international laws on doing these kind of research in Iran?
Previous published researches on psylocibin haven't mentioned how they provided this substance. unfortunately we don't have necessary facilities to synthesis pcylocibin on our own.
thank you in advance.

All Answers (2)

Scott E Hemby
High Point University
Maziar -
Psilocybin is a Schedule I controlled substance in the US and thus requires a Schedule i license to purchase or procure in the US or from US companies. If you are the recipient of a grant from the national Institute on Drug Abuse, you can request this and other compounds through NIDA Drug Supply. 
I realize you are in Tehran, but wanted to make you aware of the requirements in the US.
Best Regards, Scott
Under the United Nations drugs conventions psilocin and psilocybin are controlled drugs, and the UN guidance is that national laws of member states should make these hallucinogenic substances illegal to possess or supply without a license for medical and scientific research. I do not know what the drug laws are in Iran, but in the UK scientists typically find it very difficult to get a Home Office license to conduct research with hallucinogens like those found in the psilocybe mushroom - which was totally banned, in fresh and dried forms, by the UK's 2005 Drugs Act, which made it a Class A and Schedule 1 drug. 
However, one interesting recent avenue involves a report that psilocybin has now been found in a lichen, when it had previously only been identified in psilocybe mushrooms. Depending on the law in Iran (and other countries), it might be more feasible to use lichen rather than fungi as a source of psilocybin - it is worth checking out: http://volteface.me/psychedelic-lichen/

Similar questions and discussions

Potential problems with applying results from animal studies on humans: hallucinations and psychosis.
Discussion
10 replies
  • Henrik G.S. ArvidssonHenrik G.S. Arvidsson
As often in medicine animals are ( SADLY) used in experiments .A new study of mice shows there are important links between human and mouse minds in how they function -- and malfunction. Researchers at Washington University School of Medicine in St. Louis devised a rigorous approach to study how hallucinations are produced in the brain, providing a promising entry point to the development of much-needed new therapies for schizophrenia.
The study that was published in the journal Science, lays out a way to probe the biological roots of a defining symptom of psychosis: hallucinations. The researchers trained people and mice to complete a computer-based task that induced them to hear imaginary sounds. By analyzing performance of the task, the researchers were able to objectively measure hallucination-like events in people and mice.
This approach allowed them to study the neural circuits underlying hallucinations, potentially fully opening up the study of mental illness to the kind of scientific studies that have been fruitful for diseases of other parts of the body. My concern is that despite the positives and even if there are similarities, can a study like this be of great value when it comes to humans who has a fundamentally different cognitive ability and brain structure? I agree that we can see tendencies and the study gives an insight, however can this ever fully be transferred to humans? also see other risks as well as grave ethical concerns that applies with all experiments on animals. What are your thoughts?
Best wishes
Henrik

Related Publications

Article
Promising results suggest that psychedelic therapies could help some – but not all – treatment-resistant depression, reports Sam Wong
Article
ZUSAMMENFASSUNG In 11 Fokusgruppeninterviews diskutierten 31 Teilnehmende, gegliedert in die Zielgruppen Ärzte, Psychotherapeuten und (Ex-)Patienten ihre Einstellungen, Wünsche und Bedenken in Bezug auf die mögliche Einführung psychedelischer Therapien in das deutsche Gesundheitssystem. Folgende Themenbereiche wurden besprochen: Risiken und Potenzi...
Got a technical question?
Get high-quality answers from experts.